Keyboard shortcuts

Press ← or → to navigate between chapters

Press S or / to search in the book

Press ? to show this help

Press Esc to hide this help

Creatine Monohydrate

Pattern

A named solution to a recurring problem.

Creatine Monohydrate uses a low-cost, well-studied supplement as an adjunct to resistance training, while keeping cognition and longevity claims in their proper evidence box.

Also known as: creatine, creatine monohydrate supplementation, phosphocreatine support

Creatine is not a longevity drug. It is a compound the body uses to buffer short bursts of cellular energy, concentrated mostly in skeletal muscle and also present in the brain. The practical question is narrow: can a cheap supplement help an adult get more strength and lean-tissue benefit from training?

The answer is mostly yes for resistance training, maybe for selected cognitive outcomes, and no for any claim that creatine by itself slows aging.

Context

Creatine monohydrate sits in an unusual place in the supplement aisle. It is cheap, common, heavily studied, and useful enough that dismissing it as wellness clutter would be wrong. It is also marketed broadly enough that treating it as a default staple would be careless.

The molecule works through the creatine kinase / phosphocreatine system. During high-force or repeated short efforts, phosphocreatine helps regenerate adenosine triphosphate, the immediate energy currency used by working muscle. That is why creatine belongs naturally beside Resistance Training for Sarcopenia Prevention, sprint work, loaded carries, and other high-output efforts.

For the longevity reader, the strongest use case is not “take creatine to live longer.” It is more concrete: use creatine when the goal is to support strength, lean tissue, training quality, or rehabilitation-adjacent loading, then measure whether the training system is improving.

Problem

Creatine gets flattened into two bad stories. The first story treats it as a bodybuilding supplement for young lifters and misses its relevance to aging muscle. The second treats it as a general geroprotective compound because it touches mitochondria, brain energy metabolism, inflammation, or fatigue. Both stories lose the decision rule.

The useful decision is not whether creatine is “good.” It is whether creatine has a job. A reader who is not training, not under-eating protein, not preserving lean mass during weight loss, and not testing a bounded cognitive hypothesis is adding another bottle because the mechanism sounds plausible.

That is how a defensible supplement becomes Stack Creep. The bottle is cheap, the risk looks low, and the rationale never gets reviewed. A year later, nobody can say what endpoint it owns.

Forces

  • Creatine has one of the stronger evidence bases in sports nutrition, but the strongest evidence is still tied to training.
  • Older adults need muscle reserve, but a supplement can’t replace progressive loading or adequate protein.
  • Creatine often increases body mass through water and lean-tissue changes, which can confuse scale-based weight-loss goals.
  • Cognitive claims are plausible, but the older-adult evidence remains sparse and mixed.
  • A low monthly cost makes adoption easy, while easy adoption makes permanent use less scrutinized.
  • Kidney disease, interacting medications, dehydration risk, and medically complex disease change the conversation from public supplement guidance to clinical supervision.

Solution

Use creatine as a bounded adjunct to a strength or muscle-preservation plan, not as a standalone longevity protocol. The cleanest version starts with a defined reason: resistance training adaptation, lean-mass preservation during weight loss, low meat or fish intake, vegetarian or vegan diet, or a clinician-supervised rehabilitation context.

For most healthy adults who choose to supplement, the common maintenance pattern in the literature is 3-5 g/day of creatine monohydrate. Loading protocols exist, often around 20 g/day split into several doses for five to seven days, but loading is a speed choice. It saturates muscle faster. A steady daily dose gets there more gradually.

The decision rule matters more than the dose ritual. Pair the supplement with progressive resistance training, adequate total protein, and an endpoint: training loads, repetitions at a given load, grip strength, chair-rise performance, lean mass by DEXA, or a clear recovery marker. If the endpoint doesn’t move after a fair trial, the supplement may not deserve a permanent slot.

For cognition, keep the bar higher. The current older-adult evidence doesn’t justify treating creatine as a cognitive-reserve foundation. It may be worth watching; it isn’t a substitute for sleep, hearing correction, vascular-risk management, exercise, social connection, or cognitively demanding life.

Clinical Boundary

Do not use public supplement guidance as medical clearance if you have kidney disease, unexplained high creatinine, active cancer treatment, bipolar disorder or other medically managed psychiatric disease, pregnancy or breastfeeding, dehydration risk, a medically prescribed protein or fluid restriction, or prescription medications that require kidney monitoring. Bring creatine use to the clinician who reads your labs.

Evidence

Evidence tier: RCT (human) for lean-mass and strength augmentation when creatine is paired with resistance training; limited / disputed for cognition in healthy older adults; no human lifespan evidence. The strongest claim is functional, not geroscience.

The International Society of Sports Nutrition position stand treats creatine monohydrate as the most studied form and describes a large safety and performance literature. It reports that supplementation raises intramuscular creatine and phosphocreatine, supports high-intensity exercise capacity, and is well tolerated in studied healthy populations (Kreider et al., 2017). The aging use case still has to be read through older-adult trials, not extrapolated from young athletes.

Chilibeck and colleagues’ 2017 meta-analysis pooled 22 studies with 721 older participants, mean ages roughly 57 to 70, doing resistance training two to three days per week for 7 to 52 weeks. Compared with placebo plus training, creatine plus training produced greater lean-tissue gain, about 1.37 kg on average, and better chest-press and leg-press strength (Chilibeck et al., 2017). The result supports creatine as an adjunct. It doesn’t say creatine replaces training.

The newer evidence is directionally similar but more restrained. Sharifian and colleagues’ 2025 meta-analysis of 20 articles and 1,093 older participants found a significant effect for one-repetition maximum strength and body-fat percentage when creatine was combined with exercise training, but not for total-body bone mineral density (Sharifian et al., 2025). Liu and colleagues’ 2025 resistance-training meta-analysis found small but significant gains in lower-limb strength and lean tissue, with no clear upper-extremity strength improvement overall and several risk-of-bias cautions (Liu et al., 2025). That is a useful pattern: signal present, magnitude modest, context dependent.

Cognition is less settled. Marshall and colleagues’ 2026 systematic review included six studies and 1,542 participants aged 55 and older. Five studies reported some positive relationship between creatine and cognition, especially memory and attention, but only two were double-blind supplementation interventions, and the authors judged the evidence sparse enough to need better trials (Marshall et al., 2026). The honest reading is possibility, not practice standard.

Safety is usually discussed too casually. In healthy adults, creatine monohydrate has a good tolerability record, and serum creatinine can rise because creatine metabolism produces creatinine, not because kidney function necessarily worsened. That distinction is not a self-diagnosis tool. Kidney disease risk, abnormal labs, dehydration risk, complex medications, or clinician-imposed diet restrictions need clinical interpretation.

How It Plays Out

A 46-year-old who lifts twice per week and eats enough protein may add 3-5 g/day of creatine monohydrate for 12 weeks. The target is boring: slightly better working sets, more repeatable effort, or a small lean-mass signal. If the program isn’t progressing, creatine isn’t the missing program.

A 63-year-old intentionally losing weight has a sharper reason. Appetite is lower, calories are down, and lean-mass loss is the failure mode. Creatine can sit beside Protein Intake for Sarcopenia Prevention and resistance training as part of the muscle-preservation plan. The endpoint is not the scale. It is strength, function, and body composition.

A vegetarian strength trainee may be a cleaner candidate than a meat-heavy omnivore because baseline dietary creatine intake is lower. That does not make the supplement mandatory. It makes the hypothesis easier to test.

Consequences

Benefits. Creatine Monohydrate gives the reader a rare supplement with a plausible mechanism, low cost, common access, and human trial evidence tied to useful physical endpoints. It can make a training block slightly more productive, especially when the rest of the system is already doing the hard work.

It also teaches a good supplement decision rule. A product can be defensible without becoming a universal default. The question is: evidence-based for what outcome, in what person, paired with what behavior, and reviewed when?

Liabilities. The first liability is substitution. Creatine can become a cheap excuse to keep protein, training progression, sleep, and rehabilitation work vague. It can’t solve those gaps.

The second liability is measurement confusion. Early weight gain can reflect retained water, not fat gain. DEXA lean-mass changes can also be over-read when the functional test is flat.

The third liability is permanence. Because creatine is cheap and familiar, it can stay forever without review. The better pattern is a written reason, a bounded trial, a measurable endpoint, and a willingness to stop if the job is no longer there.

  1. Bounded byStack Creep
    Stack Creep is the failure mode when a cheap, plausible supplement loses its endpoint and becomes a permanent default.
  2. ComplementsProtein Intake for Sarcopenia Prevention
    Creatine works best when it is paired with adequate protein rather than used to compensate for a weak muscle-preservation diet.
  3. ComplementsResistance Training for Sarcopenia Prevention
    Resistance training supplies the mechanical signal that makes creatine's muscle evidence clinically useful.
  4. Contrasts withVO₂max-Targeted Intervals
    Creatine supports short, high-force work; VO₂max-targeted intervals train the cardiorespiratory ceiling.
  5. Measured byGrip Strength as Mortality Biomarker
    Grip strength can track whether a creatine-and-training experiment is changing usable strength rather than only body water.
  6. RelatedCognitive Reserve
    Creatine's cognition evidence is weaker than its muscle evidence and should be read as one small part of the reserve map.
  7. UsesEvidence Tiers
    Evidence Tiers separates the stronger resistance-training evidence from the unsettled cognitive and general-longevity claims.

Sources

This entry is a reference, not medical advice. It describes published evidence, regulatory status, and common clinical practice patterns. It does not diagnose, prescribe, or replace a clinician’s judgment for a specific person.

Creatine decisions should be clinician-supervised for people with kidney disease, abnormal kidney-function markers, medically complex disease, active cancer treatment, pregnancy, breastfeeding, prescribed protein or fluid restrictions, dehydration risk, bipolar disorder or other medically managed psychiatric disease, or medications that require kidney monitoring. Stop and seek qualified care for new swelling, severe gastrointestinal symptoms, unexplained muscle pain or weakness, dark urine, faintness, or any persistent symptom after starting a supplement.